December

Evidence-based medicines for children: important implications for new therapies at all ages Bush A. Eur Respir J 2006; 28: 1069-1072
Long-term treprostinil in pulmonary arterial hypertension: is the glass half full or half empty? Provencher S. Eur Respir J 2006; 28: 1073-1075
The mycobacterial mystery Schonfeld N. Eur Respir J 2006; 28: 1076-1078
New ways in respiratory genetics Kabesch M., Kauffmann F., von Mutius E. Eur Respir J 2006; 28: 1079-1080
Is bronchoscopic lung biopsy helpful in the management of patients with diffuse lung disease? Ensminger S. A., Prakash U. B. S. Eur Respir J 2006; 28: 1081-1084
Genotype-corrected reference values for serum angiotensin-converting enzyme Biller H., Zissel G., Ruprecht B., Nauck M., Busse Grawitz A., Muller-Quernheim J. Eur Respir J 2006; 28: 1085-1091
*Estimated numbers and prevalence of PIS and PIZ deficiency alleles of α1-antitrypsin deficiency in Asia* de Serres F. J., Blanco I., Fernandez-Bustill... E. Eur Respir J 2006; 28: 1091-1099
IL18 and IL18R1 polymorphisms, lung CT and fibrosis: a longitudinal study in coal miners Nadif R., Mintz M., Marzec J., Jedlicka A., Kauffmann F., Kleeberger S. R. Eur Respir J 2006; 28: 1100-1105
Induction of mesenchymal cell phenotypes in lung epithelial cells by adenovirus E1A Behzad A. R., Morimoto K., Gosselink J., Green J., Hogg J. C., Hayashi S. Eur Respir J 2006; 28: 1106-1117
ErbB receptor regulation by dexamethasone in mouse type II epithelial cells Dammann C. E. L., Nassimi N., Liu W., Nielsen H. C. Eur Respir J 2006; 28: 1117-1123
Parental understanding of wheeze and its impact on asthma prevalence estimates Michel G., Silverman M., Strippoli M-P. F., Zwahlen M., Brooke A. M., Grigg J., Kuehni C. E. Eur Respir J 2006; 28: 1124-1130
Home spirometry and asthma severity in children Brouwer A. F. J., Roorda R. J., Brand P. L. P. Eur Respir J 2006; 28: 1131-1137
Reduced bronchial CD4+ T-cell density in smokers with occupational asthma Sjaheim T., Kongerud J., Bjortuft O., Drablos P. A., Malterud D., Halstensen T. S. Eur Respir J 2006; 28: 1138-1144
TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma Miller M. K., Lee J. H., Blanc P. D., Pasta D. J., Gujrathi S., Barron H., Wenzel S. E., Weiss S. T. for the TENOR Study Group Eur Respir J 2006; 28: 1145-1155
Genetic determinants of C-reactive protein in COPD Hersh C. P., Miller D. T., Kwiatkowski D. J., Silverman E. K. Eur Respir J 2006; 28: 1156-1162
Airway neutrophilia in COPD is not associated with increased neutrophil survival Rytila P., Plataki M., Bucchieri F., Uddin M., Nong G., Kinnula V. L., Djukanovic R. Eur Respir J 2006; 28: 1163-1169
Characterisation of dendritic cell subsets in lung cancer micro-environments Bergeron A., El Hage F., Kambouchner M., Lecossier D., Tazi A. Eur Respir J 2006; 28: 1170-1177
Identification of differentially expressed proteins in human malignant pleural effusions Hsieh W-Y., Chen M-W., Ho H-T., You T-M., Lu Y-T. Eur Respir J 2006; 28: 1178-1185
EU-USA pathology panel for uniform diagnosis in randomised controlled trials for HRCT screening in lung cancer Thunnissen F. B., Kerr K. M., Brambilla E., Comin C. E., Franklin W. A., Guldhammerskov B., Westra W. H., Flieder D. B. Eur Respir J 2006; 28: 1186-1189
NT-proBNP reflects right ventricular structure and function in pulmonary hypertension Gan C. T., McCann G. P., Marcus J. T., van Wolferen S. A., Twisk J. W., Boonstra A., Postmus P. E., Vonk-Noordegraaf A. Eur Respir J 2006; 28: 1190-1194
Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil Barst R. J., Galie N., Naeije R., Simonneau G., Jeffs R., Arneson C., Rubin L. J. Eur Respir J 2006; 28: 1195-1203
Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics Fowler S. J., French J., Screaton N. J., Foweraker J., Condliffe A., Haworth C. S., Exley A. R., Bilton D. Eur Respir J 2006; 28: 1204-1210
Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients Dailloux M., Abalain M. L., Laurain C., Lebrun L., Loos-Ayav C., Lozniewski A., Maugein J., the French Mycobacteria Study Group Eur Respir J 2006; 28: 1211-1215
Healthcare workers with tuberculosis infected during work de Vries G., Sebek M. M. G. G., Lambregts-van Wee... C. S. B. Eur Respir J 2006; 28: 1216-1221
Obstructive sleep apnoea and oral breathing in patients free of nasal obstruction Koutsourelakis I., Vagiakis E., Roussos C., Zakynthinos S. Eur Respir J 2006; 28: 1222-1228
Saliva is one likely source of leukotriene B4 in exhaled breath condensate Gaber F., Acevedo F., Delin I., Sundblad B-M., Palmberg L., Larsson K., Kumlin M., Dahlen S-E. Eur Respir J 2006; 28: 1229-1235
Utility of exhaled nitric oxide as a noninvasive biomarker of lung inflammation in a disease model Birrell M. A., McCluskie K., Hardaker E., Knowles R., Belvisi M. G. Eur Respir J 2006; 28: 1236-1244
Mortality in COPD: role of comorbidities Sin D. D., Anthonisen N. R., Soriano J. B., Agusti A. G. Eur Respir J 2006; 28: 1245-1257
Evolution and respiratory genetics Le Souef P. N., Candelaria P., Goldblatt J. Eur Respir J 2006; 28: 1258-1263
Transbronchial and transoesophageal (ultrasound-guided) needle aspirations for the analysis of mediastinal lesions Herth F. J. F., Rabe K. F., Gasparini S., Annema J. T. Eur Respir J 2006; 28: 1264-1275
Severe airflow obstruction and eosinophilic lung disease after Stevens-Johnson syndrome Shah A. P., Xu H., Sime P. J., Trawick D. R. Eur Respir J 2006; 28: 1276-1279
Caucasian race and lung function: time to revisit the racial groups used in reference values Kiviranta K., Haahtela T. Eur Respir J 2006; 28: 1280
Components of airway disease Hahn D. L. Eur Respir J 2006; 28: 1281
Three new cases of apparent occupational asthma in swine confinement facility employees Dosman J. A., Lawson J. A., Kirychuk S. P., Cormier Y., Biem J., Koehncke N. Eur Respir J 2006; 28: 1281-1282
The specificity of interferon-γ-based blood tests in the identification of latent tuberculosis infection Granger C. Eur Respir J 2006; 28: 1283
Lymphangioleiomyomatosis Zarogiannis S., Hatzoglou C., Molyvdas P. A., Gourgoulianis K. Eur Respir J 2006; 28: 1284
Cost-optimisation of screening for latent tuberculosis in close contacts Sadatsafavi M., Najafzadeh M. Eur Respir J 2006; 28: 1285
From the authors Diel R. Eur Respir J 2006; 28: 1285-1286
Therapy of exophytic bronchial tumorous stenosis by flexible cryoprobe Schumann C., Kropf C., Wibmer T., Merk T., Kruger S. Eur Respir J 2006; 28: 1286-1287
From the authors Vergnon J-M. Eur Respir J 2006; 28: 1287
Is forced expiratory volume in six seconds a valid alternative to forced vital capacity? Vandevoorde J., Swanney M. Eur Respir J 2006; 28: 1288-1289
From the authors Hansen J., Sun X-G., Wasserman K. Eur Respir J 2006; 28: 1289-1290
Epidemiology and costs of COPD Blanc P. D., Balmes J. R. Eur Respir J 2006; 28: 1290
Cryptogenic organising pneumonia Kastelik J. A., Greenstone M., McGivern D. V., Morice A. H. Eur Respir J 2006; 28: 1291
ANGIOTENSIN II BLOCKERS IN OBSTRUCTIVE PULMONARY DISEASE: A RANDOMISED CONTROLLED TRIAL. S. ANDREAS. EUR RESPIR J 2006; 28: 670-671. Eur Respir J 2006; 28: 1292
PREVALENCE AND SOCIOECONOMIC ASSOCIATIONS OF ASTHMA AND ALLERGIC RHINITIS IN NORTHERN AFRICA. V. GEORGY, H.I. FAHIM, M. EL GAAFARY AND S. WALTERS. EUR RESPIR J 2006; 28: 756-762. Eur Respir J 2006; 28: 1292
Principles and Practice of Mechanical Ventilation. Second Edition Ambrosino N. Eur Respir J 2006; 28: 1293
Disorders of the Respiratory Tract. Common Challenges in Primary Care Thiadens H.A. Eur Respir J 2006; 28: 1293